CN Patent

CN115697314A — 安非他酮和右美沙芬组合用于治疗神经病症的用途

Assigned to Antecip Bioventures II LLC · Expires 2023-02-03 · 3y expired

What this patent protects

本文提供了用于治疗与阿尔茨海默氏病相关的重度抑郁症或激越的方法，包括施用包含安非他酮和右美沙芬的组合治疗。具体提供的方法包括向约41岁或年龄更大的人受试者每天一次或每天两次施用约105mg盐酸安非他酮和约45mg氢溴酸右美沙芬。

USPTO Abstract

本文提供了用于治疗与阿尔茨海默氏病相关的重度抑郁症或激越的方法，包括施用包含安非他酮和右美沙芬的组合治疗。具体提供的方法包括向约41岁或年龄更大的人受试者每天一次或每天两次施用约105mg盐酸安非他酮和约45mg氢溴酸右美沙芬。

Drugs covered by this patent

Patent Metadata

Patent number: CN115697314A
Jurisdiction: CN
Classification: —
Expires: 2023-02-03
Drug substance claim: No
Drug product claim: No
Assignee: Antecip Bioventures II LLC
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.